GNGT1 and gastric cancer: On the other hand, Chen et al focused on understanding trastuzumab resistance in gastric cancer, identifying GNGT1, KRT7, KRT16, SOX9, and TIMP1 as promising diagnostic biomarkers for gastric cancer.